Adjuvant Nivolumab: A New Standard of Care in High-risk MIUC?

The checkpoint inhibitor nivolumab is efficacious and well tolerated when used as adjuvant therapy in patients who have undergone radical…

Caelyx

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CAELYX® pegylated liposomal doxorubicin hydrochloride Consumer Medicine…

Kanjinti

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KANJINTI® Intravenous infusion Contains the active ingredient…

Zavedos Capsules & Injection

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZAVEDOS® Idarubicin hydrochloride Consumer Medicine Information What…

Pemetrexed Apotex

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PEMETREXED APOTEX POWDER FOR INJECTION Contains the…